STING1 and cancer: According to recent studies, DNA damages and DDR deficiencies induce the activation of STING and NF-κB pathways, leading to inflammation and infiltration of tumors by immune cells across multiple types of cancers, a prerequesite of tumor-killing effect of ICI [126,127,128,129,130].